Related Experiment Video
Updated: Mar 29, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
[Atherosclerosis: from etiology to its possible influencing]
Insights
Targeting both lipid accumulation and renin-angiotensin-aldosterone system (RAS) hyperactivity slows vascular changes. Simultaneous treatment offers synergistic effects, improving cardiovascular prevention and patient prognosis.
Area of Science:
- Cardiovascular Medicine
- Pathophysiology
- Pharmacology
Background:
- Atherosclerosis involves both lipid accumulation (classical lesion) and arterial wall changes (medial hypertrophy, smooth muscle cell activation).
- Different risk factors influence these distinct pathological processes, with lipoproteins driving classical atherosclerosis and renin-angiotensin-aldosterone system (RAS) hyperactivity impacting arterial media.
Purpose of the Study:
- To investigate the synergistic effects of simultaneously targeting lipid metabolism and RAS hyperactivity in cardiovascular disease.
- To evaluate the impact of combined therapeutic strategies on both atherosclerotic plaque development and arterial wall remodeling.
Main Methods:
- Review of experimental and clinical studies examining interventions targeting low-density lipoprotein (LDL) levels and RAS overactivity.
- Analysis of data on cardiovascular outcomes, including atherothrombotic events and medial/ventricular changes.
Main Results:
- Simultaneous intervention in lipid lowering and RAS inhibition demonstrates synergistic effects in slowing vascular pathology.
- Combined strategies reduce not only atherothrombotic events like acute coronary syndrome but also heart failure and arrhythmias.
Conclusions:
- Targeting both classical atherosclerotic lesions and arterial media changes is crucial for effective cardiovascular prevention.
- Combined therapeutic approaches targeting atherogenic lipids and RAS hyperactivity offer superior outcomes compared to single-modality treatments.
Abstract:
Atherosclerosis as an inflammatory process affecting vessel wall has more forms usually occurring together. Classical atherosclerotic vascular lesion characterised by lipid accumulation in the subendothelial space is frequently accompanied by changes in deeper layers of arterial wall, in which increased extracellular tissue mass and smooth muscle cells activation represent the most prominent feature. Due to a specific constellation of risk factors the first or second pathology may be more expressed. While initiation and progression of classical atherosclerosis are mostly driven by lipoproteins (especially of LDL class) the most important factor of arterial media changes seem to be different risk factors e.g. hyperactivity of renin-angiotensin-aldosterone system (RAS). Influencing these two basic pathogenic mechanisms undoubtedly slows down the course of vascular changes and impacts positively on the prognosis of the patients. It is noteworthy, that simultaneous targeting of both of these mechanisms yields synergistic effects as evidenced both by experimental and clinical works. Using the opportunities offered by intensive lowering of atherogenic plasma lipids and over activation of the RAS system reduce not only the incidence of typical atherotromobotic complications (e.g. acute coronary syndrome) but also the events caused by changes of medial part of arterial wall or left myocardial ventricle (malignant arrhythmia, heart failure). These two strategies represent necessary conditions for successful cardiovascular prevention.
More Related Videos
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
13:45A Method to Study the Correlation Between Local Collagen Structure and Mechanical Properties of Atherosclerotic Plaque Fibrous Tissue
Published on: November 11, 2022
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Artery Disease I: Introduction